Latest AI and machine learning research in other cancers for healthcare professionals.
Messenger RNA-lipid nanoparticle (mRNA-LNP) therapeutics have emerged as a versatile drug modality, enabling in vivo protein expression for vaccines, cancer immunotherapy, and the treatment of genetic and metabolic diseases. Although mRNA-LNP platforms achieved rapid clinical success during the COVID-19 pandemic, most candidates fail to progress beyond preclinical development, largely due to the l...
OBJECTIVE: To benchmark zero-shot generative pre-trained transformer (GPT)-based multimodal large language models (MLLMs) for pressure injury (PI) staging from photographs and quantify the effects of prompt strategy, structured outputs, and clinically meaningful label granularity. APPROACH: We performed a retrospective observational benchmark using 1,091 public, de-identified PI photographs labele...
Circulating tumor DNA (ctDNA) enables noninvasive tumor genotyping, yet its concordance with tissue remains unclear. Using a 437-gene panel in 1111 pa...
Chemoresistance to 5-fluorouracil (5-FU) remains a critical barrier in colorectal cancer (CRC) management. This study integrates multi-omics data from...
Emerging evidence indicates that aberrant cholesterol metabolism in macrophages plays a role in tumorigenesis, however, how specific metabolites relea...
BACKGROUND: Pancreatic adenocarcinoma (PAAD) has an extremely poor prognosis, and existing prognostic markers fail to fully capture the complex hetero...
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) strongly resists apoptosis via baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5) and ...
BACKGROUND: To evaluate the single-session agreement between treatment recommendations generated by ChatGPT and Gemini and real-world decisions made b...
Oncolytic viruses (OVs) represent a versatile platform for cancer immunotherapy, capable of selectively infecting and lysing tumor cells while trigger...
BACKGROUND: Vessels encapsulating tumor clusters (VETCs), a CD34-positive vascular pattern in hepatocellular carcinoma (HCC), are linked to aggressive...
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality, with transcatheter arterial chemoembolization (TACE) being a widel...
The 17th Annual Frontiers in Cancer Science (FCS) conference (2025) highlighted the convergence of multiomics, computational biology, and ancestry-spe...
BACKGROUND: While artificial intelligence's (AI's) transformative potential in health care is widely acknowledged, its application in highly sensitive...
BACKGROUND AND OBJECTIVE: Metastatic hormone-sensitive prostate cancer (mHSPC) exhibits heterogeneous progression patterns, with early progression to ...
OBJECTIVE: Lung adenocarcinoma (LUAD) molecular heterogeneity limits traditional prognostic models. Given the emerging role of neural regulation (NR) ...
The surgical procedures for primary lung cancer and metastatic lung tumors differ. An intraoperative diagnosis is important for surgical procedure dec...
Malignant or high-grade vocal fold disease is usually judged across repeated laryngoscopic views at different observation distances and fields of view...
Metastatic renal cell carcinoma remains clinically challenging because of heterogeneous outcomes and limited predictive biomarkers for immunotherapy. ...
Breast cancer is one of the most prevalent and lethal malignancies affecting women globally. The increasing resistance to current therapeutic strategi...